GSK recalls nearly 600,000 asthma inhalers in U.S.
Friday, April 7, 2017 - 14:31
in Health & Medicine
GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect that may cause them to deliver fewer doses of the medicine than indicated.